Trials / Terminated
TerminatedNCT00835874
Probiotic Administartion to Mothers of Preterm Infants to Prevent Necrotizing Enterocolitis and Sepsis
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Tel-Aviv Sourasky Medical Center · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
We hypothesize that supplementing maternal diet with probiotics will decrease the incidence of feeding intolerance, necrotizing enterocolitis and sepsis in preterm infants fed breastmilk.
Detailed description
Oral probiotics have previously been shown to prevent necrotizing enterocolitis in preterm infants. A few reports of sepsis by a probiotic bacteria have impeded implementation of oral probiotic supplementation in most NICUs. Considering the proven immunomodulatory effect of maternal probiotics on breastfed infants of atopic mothers, we would like to explore the indirect effects of maternal probiotics on preterm infants
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Probiotics | Lactobacillus acidophilus, b.lactis capsule. Once daily.2X 10 by the power of 10 bacteria per dose. |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-02-04
- Last updated
- 2012-08-02
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00835874. Inclusion in this directory is not an endorsement.